Phosphate-Trapping Liposomes for Long-Term Management of Hyperphosphatemia

Chen Tzror-Azankot, Adi Anaki, Tamar Sadan, Menachem Motiei, Rachela Popovtzer

Research output: Contribution to journalArticlepeer-review


Hyperphosphatemia is a typical complication of end-stage renal disease, characterized by elevated and life-threatening serum phosphate levels. Hemodialysis does not enable sufficient clearance of phosphate, due to slow cell-to-plasma kinetics of phosphate ions; moreover, dietary restrictions and conventional treatment with oral phosphate binders have low success rates, together with adverse effects. Here, we developed a new concept of phosphate-trapping liposomes, to improve and prolong the control over serum phosphate levels. We designed liposomes modified with polyethylene glycol and encapsulated with the phosphate binder ferric citrate (FC liposomes). These liposomes were found to trap phosphate ions in their inner core, and thereby lower free phosphate ion concentrations in solution and in serum. The FC liposomes showed higher phosphate binding ability as phosphate concentrations increased. Moreover, these liposomes showed a time-dependent increase in uptake of phosphate, up to 25 h in serum. Thus, our findings demonstrate effective long-term phosphate trapping by FC liposomes, indicating their potential to reduce serum phosphate toxicity and improve current management of hyperphosphatemia.

Original languageEnglish
Article number7779
Issue number21
StatePublished - Nov 2022

Bibliographical note

Publisher Copyright:
© 2022 by the authors.


  • ferric citrate
  • hyperphosphatemia
  • liposomes
  • phosphate binder


Dive into the research topics of 'Phosphate-Trapping Liposomes for Long-Term Management of Hyperphosphatemia'. Together they form a unique fingerprint.

Cite this